Screener
Utah Medical Products UTMD EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Utah Medical Products’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 1:57 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001096906-26-001210
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Provision for income taxes | 600 | 788 | 1,179 | 1,605 |
| Net income | $2,686 | $3,048 | $5,290 | $6,089 |
| Earnings per common share (basic) | $0.84 | $0.94 | $1.66 | $1.86 |
| Earnings per common share (diluted) | $0.84 | $0.94 | $1.66 | $1.86 |
| Shares outstanding - basic | 3,184 | 3,246 | 3,184 | 3,278 |
| Shares outstanding - diluted | 3,184 | 3,246 | 3,184 | 3,278 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation net of taxes of $0 in all periods | $(34) | $1,828 | $(536) | $2,546 |
Cover / Front Matter
FAQ
- What is Utah Medical Products's EPS (diluted)?
- Utah Medical Products (UTMD) reported EPS (diluted) of $0.84 in Q2 2026.
- How has Utah Medical Products's EPS (diluted) changed year-over-year?
- Utah Medical Products's EPS (diluted) decreased by 10.6% year-over-year, from $0.94 to $0.84.
- What is the long-term trend for Utah Medical Products's EPS (diluted)?
- Over 4 years (2021 to 2025), Utah Medical Products's EPS (diluted) has grown at a -3.7% compound annual growth rate (CAGR), from $4.05 to $3.48.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Utah Medical Products's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude